Concepedia

Tara Reshadmanesh

TR

Statistics

Publications

3

Citations

77

H-Index

3

Active since

2021

Affiliations

Case Western Reserve University(Current)

Zanjan University of Medical Sciences

University Hospitals of Cleveland

Shahid Beheshti University of Medical Sciences

Binghamton University

Tara Reshadmanesh is an author at Case Western Reserve University specializing in pharmacology, cardiovascular disease, and coronary artery disease pharmacotherapy.

ORCID

Publications per year

2021–2023

3

Publications

3

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

Sepehr Gohari, Tara Reshadmanesh, Hadi Khodabandehloo et al. · Diabetology & Metabolic Syndrome · 2022 · 54 citations · Full text

, , +17

Empagliflozin improves high-sensitive cardiac troponin-I and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD Trial

Homa Taheri, Hossein Chiti, Tara Reshadmanesh et al. · Journal of Diabetes & Metabolic Disorders · 2023 · 13 citations · Full text

, , +16

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

Sepehr Gohari, Tara Reshadmanesh, Hadi Khodabandehloo et al. · BMC Cardiovascular Disorders · 2021 · 10 citations · Full text

, , +16

1–3 of 3